Related Articles
Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc.
Body fluid MMP-2 as a putative biomarker in metastatic breast cancer
Gemcitabine suppresses malignant ascites of human pancreatic cancer: correlation with VEGF expression in ascites
Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells.
Correlation of the expression of vascular endothelial growth factor and its receptors with microvessel density in ovarian cancer